Literature DB >> 1319405

Alterations in protein expression and complement resistance of pathogenic Naegleria amoebae.

D M Toney1, F Marciano-Cabral.   

Abstract

Highly pathogenic strains of Naegleria fowleri activate the alternative complement pathway but are resistant to lysis. In contrast, weakly pathogenic and nonpathogenic Naegleria spp. activate the complement pathway and are readily lysed. The present study was undertaken to determine whether surface components on amoebae accounted for resistance to complement lysis. Enzymatic removal of surface components from highly pathogenic N. fowleri with phosphatidylinositol-specific phospholipase C or with endoglycosidase H increased the susceptibility of these amoebae to complement-mediated lysis. Similar treatment of nonpathogenic amoebae had no effect on susceptibility to complement. Tunicamycin treatment of highly and weakly pathogenic N. fowleri increased susceptibility to lysis by complement in a dose-related manner. Tunicamycin treatment did not alter the susceptibility of nonpathogenic amoebae to complement. Proteins of 234 and 47 kDa were detected in supernatant fluid from phosphatidylinositol-specific phospholipase C-treated highly pathogenic amoebae but not in supernatant fluid from phosphatidylinositol-specific phospholipase C-treated weakly pathogenic amoebae. Electrophoretic analysis of iodinated surface proteins of highly pathogenic N. fowleri revealed species of 89, 60, 44, and 28 kDa. Western immunoblots of lysates from surface-iodinated amoebae were stained with biotinylated concanavalin A or biotinylated Ulex europaeus agglutinin I. Surface proteins, identified in highly pathogenic amoebae by iodination, were shown to be glycoproteins by lectin analysis specific for the detection of mannose and fucose residues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319405      PMCID: PMC257235          DOI: 10.1128/iai.60.7.2784-2790.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures.

Authors:  M A Ferguson; A F Williams
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 2.  Decay-accelerating factor: biochemistry, molecular biology, and function.

Authors:  D M Lublin; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  Glycoproteins: what are the sugar chains for?

Authors:  J C Paulson
Journal:  Trends Biochem Sci       Date:  1989-07       Impact factor: 13.807

Review 4.  Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors.

Authors:  M G Low
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

5.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

Authors:  A Nicholson-Weller; J Burge; D T Fearon; P F Weller; K F Austen
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

6.  Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis.

Authors:  L Y Whiteman; F Marciano-Cabral
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

7.  Biological activities of the two major components of tunicamycin.

Authors:  W C Mahoney; D Duksin
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

8.  Activation of the alternative complement pathway by Naegleria fowleri.

Authors:  T W Holbrook; R J Boackle; B W Parker; J Vesely
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid.

Authors:  M E Medof; E I Walter; W L Roberts; R Haas; T L Rosenberry
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

10.  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Authors:  A Davies; D L Simmons; G Hale; R A Harrison; H Tighe; P J Lachmann; H Waldmann
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

Review 2.  Pathogenesis of acanthamoeba keratitis.

Authors:  Noorjahan Panjwani
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

3.  Pathogenic Naegleria fowleri and non-pathogenic Naegleria lovaniensis exhibit differential adhesion to, and invasion of, extracellular matrix proteins.

Authors:  Melissa Jamerson; Bruno da Rocha-Azevedo; Guy A Cabral; Francine Marciano-Cabral
Journal:  Microbiology       Date:  2012-01-05       Impact factor: 2.777

Review 4.  Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.

Authors:  Hongze Zhang; Xunjia Cheng
Journal:  Front Med       Date:  2021-11-26       Impact factor: 4.592

5.  Differences between Naegleria fowleri and Naegleria gruberi in expression of mannose and fucose glycoconjugates.

Authors:  Isaac Cervantes-Sandoval; José Jesús Serrano-Luna; Judith Pacheco-Yépez; Angélica Silva-Olivares; Víctor Tsutsumi; Mineko Shibayama
Journal:  Parasitol Res       Date:  2010-01-23       Impact factor: 2.289

6.  Immunological characterizations of a cloned 13.1-kilodalton protein from pathogenic Naegleria fowleri.

Authors:  Myoung-Soo Cho; Suk-Yul Jung; Sun Park; Kyongmin Hwang Kim; Hyung-Il Kim; Seonghyang Sohn; Han-Jip Kim; Kyung-Il Im; Ho-Joon Shin
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

7.  Genome-wide identification of pathogenicity factors of the free-living amoeba Naegleria fowleri.

Authors:  Denise C Zysset-Burri; Norbert Müller; Christian Beuret; Manfred Heller; Nadia Schürch; Bruno Gottstein; Matthias Wittwer
Journal:  BMC Genomics       Date:  2014-06-19       Impact factor: 3.969

8.  Genomics and transcriptomics yields a system-level view of the biology of the pathogen Naegleria fowleri.

Authors:  Emily K Herman; Alex Greninger; Mark van der Giezen; Michael L Ginger; Inmaculada Ramirez-Macias; Haylea C Miller; Matthew J Morgan; Anastasios D Tsaousis; Katrina Velle; Romana Vargová; Kristína Záhonová; Sebastian Rodrigo Najle; Georgina MacIntyre; Norbert Muller; Mattias Wittwer; Denise C Zysset-Burri; Marek Eliáš; Claudio H Slamovits; Matthew T Weirauch; Lillian Fritz-Laylin; Francine Marciano-Cabral; Geoffrey J Puzon; Tom Walsh; Charles Chiu; Joel B Dacks
Journal:  BMC Biol       Date:  2021-07-22       Impact factor: 7.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.